| Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study LE Gialloreti, M Merito, P Pezzotti, L Naldi, A Gatti, M Beillat, L Serradell, ... BMC infectious diseases 10, 1-11, 2010 | 215 | 2010 |
| Current management of herpes zoster: the European view A Volpi, G Gross, J Hercogova, RW Johnson American journal of clinical dermatology 6, 317-325, 2005 | 132 | 2005 |
| Transmission of human herpesvirus 8: an update F Pica, A Volpi Current opinion in infectious diseases 20 (2), 152-156, 2007 | 119 | 2007 |
| Management of herpes zoster and post-herpetic neuralgia now and in the future RJ Whitley, A Volpi, M McKendrick, A van Wijck, AL Oaklander Journal of clinical virology 48, S20-S28, 2010 | 118 | 2010 |
| A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication SJ Griffiths, M Koegl, C Boutell, HL Zenner, CM Crump, F Pica, ... PLoS Pathogens 9 (8), e1003514, 2013 | 116 | 2013 |
| Severe complications of herpes zoster A Volpi Herpes 14, 35-39, 2007 | 106 | 2007 |
| Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing α5β1 integrin expression and function G Barillari, L Albonici, S Incerpi, L Bogetto, G Pistritto, A Volpi, B Ensoli, ... Atherosclerosis 154 (2), 377-385, 2001 | 100 | 2001 |
| Clinical and psychosocial correlates of post‐herpetic neuralgia A Volpi, A Gatti, F Pica, S Bellino, LT Marsella, AF Sabato Journal of medical virology 80 (9), 1646-1652, 2008 | 89 | 2008 |
| Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy G Parruti, M Tontodonati, C Rebuzzi, E Polilli, F Sozio, A Consorte, ... BMC medicine 8, 1-10, 2010 | 86 | 2010 |
| Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy. G Moroni, G Banfi, A Montoli, A Bucci, T Bertani, M Ravelli, C Pozzi, ... Clinical nephrology 38 (2), 81-85, 1992 | 85 | 1992 |
| Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies A Volpi, RJ Whitley, R Ceballos, S Stagno, L Pereira Journal of Infectious Diseases 147 (6), 1119-1120, 1983 | 77 | 1983 |
| Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system. A Volpi Herpes: the Journal of the IHMF 11, 120A-127A, 2004 | 76 | 2004 |
| Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or … M Branca, C Giorgi, D Santini, L Di Bonito, M Ciotti, A Benedetto, P Paba, ... Journal of clinical pathology 59 (1), 40-47, 2006 | 67 | 2006 |
| Carotid plaque calcification predicts future cardiovascular events in type 2 diabetes S Vigili de Kreutzenberg, GP Fadini, S Guzzinati, M Mazzucato, A Volpi, ... Diabetes Care 38 (10), 1937-1944, 2015 | 62 | 2015 |
| A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem … G Gentile, A Picardi, A Capobianchi, A Spagnoli, L Cudillo, T Dentamaro, ... BMC Infectious Diseases 6, 1-10, 2006 | 59 | 2006 |
| Herpes zoster in frail elderly patients: prevalence, impact, management, and preventive strategies E Zorzoli, F Pica, G Masetti, E Franco, A Volpi, G Gabutti Aging clinical and experimental research 30, 693-702, 2018 | 50 | 2018 |
| Clinical and psychosocial correlates of acute pain in herpes zoster A Volpi, A Gatti, G Serafini, B Costa, B Suligoi, F Pica, LT Marsella, ... Journal of clinical virology 38 (4), 275-279, 2007 | 50 | 2007 |
| Complications of herpes zoster in immunocompetent older adults: incidence in vaccine and placebo groups in two large phase 3 trials M Kovac, H Lal, AL Cunningham, MJ Levin, RW Johnson, L Campora, ... Vaccine 36 (12), 1537-1541, 2018 | 47 | 2018 |
| Safety profile of the adjuvanted recombinant zoster vaccine: pooled analysis of two large randomised phase 3 trials M López-Fauqued, L Campora, F Delannois, M El Idrissi, L Oostvogels, ... Vaccine 37 (18), 2482-2493, 2019 | 45 | 2019 |
| Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50 years and older D Curran, L Oostvogels, T Heineman, S Matthews, J McElhaney, S McNeil, ... The Journals of Gerontology: Series A 74 (8), 1231-1238, 2019 | 40 | 2019 |
